Research & Markets: Renal Stones/Calculi Global Clinical Trials Review, H1, 2015 - Espy the Commercial Landscape of the Major...
March 31 2015 - 5:45AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/jmjl38/renal) has
announced the addition of the "Renal Stones/Calculi Global Clinical
Trials Review, H1, 2015" report to their offering.
Renal Stones/Calculi Global Clinical Trials Review, H1, 2015"
provides data on the Renal Stones/Calculi clinical trial scenario.
This report provides elemental information and data relating to the
clinical trials on Renal Stones/Calculi. It includes an overview of
the trial numbers and their recruitment status as per the site of
trial conduction across the globe. The databook offers a
preliminary coverage of disease clinical trials by their phase,
trial status, prominence of the sponsors and also provides briefing
pertaining to the number of trials for the key drugs for treating
Renal Stones/Calculi.
Reasons to buy
- Understand the dynamics of a particular indication in a
condensed manner
- Abridged view of the performance of the trials in terms of
their status, recruitment, location, sponsor type and many
more
- Obtain discontinued trial listing for trials across the
globe
- Espy the commercial landscape of the major Universities /
Institutes / Hospitals or Companies
Top Companies Participating in Renal Stones/Calculi
Therapeutics Clinical Trials
- Astellas Pharma Inc.
- The Himalaya Drug Company
- Omeros Corporation
- Allena Pharmaceuticals, Inc.
- Indus Biotech Private Limited
- Hamad Medical Corporation
- Catalysis, S.L.
- Actavis plc
For more information visit
http://www.researchandmarkets.com/research/jmjl38/renal
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Pharmaceuticals, Clinical Trials